The Global Biosurgery Market report estimated rising cost of surgical procedures, high price of biosurgery products, and lack of skilled personnel for the effective use of biosurgery products may hamper the growth of the market during the assessment period.
Biosurgery products are biologically active products used in various surgeries to facilitate hemostasis and tissue sealing. The growing geriatric population, an increasing number of surgeries, and rising occurrences of trauma and sports-related injuries are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. For instance, in December 2015, Medtronic plc announced the US Food and Drug Administration (FDA) approval of its product Infuse Bone Graft for additional spine surgery indications.
Leading Company Profiles
Baxter International, Inc.
Braun Melsungen AG
Johnson & Johnson
MAQUET Holding B.V. & Co. Kg. (Getinge Group)
Cohera Medical Inc.
Integra Lifesciences Holdings Corporation
Commonwealth Serum Laboratories (CSL)
Kuros Biosciences Ltd.
Get Exclusive Sample Copy of Biosurgery Market Report spread across 100 Premium Pages, Top 10 Companies Profile and Supported with 100 Tables and Figures is Available @ https://www.marketresearchfuture.com/sample_request/6246 .
The Global Biosurgery Market has been segmented on the basis of product, source, and application.
On the basis of product, the market has been classified as bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The bone-graft substitutes segment has been further divided into demineralized bone matrix, synthetic bone grafts, bone morphogenetic proteins, and other bone-graft substitutes. The hemostatic agents segment has been further divided into thrombin-based hemostatic agents, oxidized regenerated cellulose-based hemostatic agents, and combination hemostatic agents. The soft-tissue attachments segment has been classified as synthetic meshes and biological meshes. The surgical sealants and adhesives segment has been divided into natural and synthetic sealants and adhesives. The natural sealants sub-segment has been segmented into fibrin sealants, collagen-based sealants, gelatin-based sealants, albumin-based sealants, and other natural sealants. The synthetic sealants segment has been divided into peg hydrogels, cyanoacrylate-based sealants and adhesives, urethane-based sealants and adhesives, and others. Furthermore, the adhesion barriers segment has been sub-segmented into synthetic and natural adhesion barriers. The synthetic adhesion barriers segment includes hyaluronic acid-based, peg-based, and ther synthetic barriers. The natural adhesion barriers segment includes collagen- and fibrin-based adhesion barriers.
The market, by source, has been segmented into biological and natural products. On basis of application, the market has been divided into neurological surgery, general surgery, cardiovascular surgery, orthopedic surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and urology surgery.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biosurgery market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European biosurgery market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The biosurgery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biosurgery market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Summary of Biosurgery Market:
The Americas are likely to dominate the global biosurgery market owing to the rising prevalence of chronic diseases in the aging population, increase in the number of surgical procedures, the presence of a well-established healthcare system, growing incidences of trauma-related injuries, and adoption of highly advanced technology. According to the American Association for the Surgery of Trauma, injury accounts for over 150,000 deaths and over 3 million non-fatal injuries are reported per year in the US.
The European market is expected to be the second-largest biosurgery market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of surgeries due to changing lifestyles is contributing to the growth of the market in this region.
Asia-Pacific is expected to be the fastest-growing biosurgery market during the forecast period owing to the increasing prevalence of chronic diseases, rising investments in healthcare and expansions by market players in the region. For instance, in February 2014, Cryolife, Inc. established a new subsidiary in Asia-Pacific.
The market in the Middle East & Africa is expected to account for the smallest share of the global biosurgery market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Ask to Experts @ https://www.marketresearchfuture.com/enquiry/6246 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312